MolBio2023 Conference

1 DAY LEFT for MOLBIO23
Exciting News: Our Latest Sponsor - The Panhellenic Association of Pharmaceutical Companies (PEF) 🌐

We're thrilled to announce our esteemed sponsor for the upcoming event – The Panhellenic Association of Pharmaceutical Companies (PEF). As the institutional body representing the Greek pharmaceutical industry, PEF plays a pivotal role in shaping the landscape of healthcare and pharmaceuticals in Greece.

🌟 About PEF:
PEF is dedicated to fostering the growth and advancement of the Greek pharmaceutical sector, a dynamic and strategic component of the National Economy. With a focus on producing high-quality generic drugs adhering to stringent quality assurance (QA) standards and good manufacturing practices (GMP) regulations, PEF aims to contribute significantly to citizen healthcare and enhance the overall quality of life.

Key Objectives of PEF Include:
Advancing pharmaceutical science for the benefit of citizen healthcare.
Ensuring complete coverage of the Greek pharmaceutical market with high-quality drugs at reasonable costs.
Promoting the healthy growth of the pharmaceutical market.
Supporting the development of modern and competitive Greek production units to reduce dependence on imported drugs.
🌍 Connect with PEF:Explore more about PEF's initiatives and contributions to the pharmaceutical industry by visiting their website: www.pef.gr

🎉 Don't Miss the Opportunity

📅 Save the Date: 13/12/2023
📍 Location: Serafio City of Athens
🎟️ Register Today: LINK on BIO

🔬 Get ready for a molecular adventure at MolBio2023 Conference on December 13th!
🌐 Our program is packed with groundbreaking sessions, expert talks, and the future of molecular biology. 🧬 Mark your calendars and join us🚀
Registrations are open on our website

Link in Bio

International MSc Molecular Biomedicine, Athens - Greece

"

It is a great honor to introduce our last speaker, Vasiliki Mollaki, Geneticist, Ethics Expert & Ethics Advisor, Hellenic National Commission for Bioethics and Technoethics.

13th of December is so close!
3 days left to register!! 🎊🎊🎊

Go visit our Website 🕸️

Link in bio 🔗

So happy to announce Stamatiki Kritas, Business Development Manager, Hellenic Bio Cluster (HBio) as our next speaker at Molecular Biomedicine 6th Annual Conference.

"Presicion Medicine : from genetic fingerprints to individual treatments "
💯🎉

👈Registrations are open on our Website ‼️‼️

Link in bio 🔗

📣NEXT SPEAKER: The Research Director- Professor Level, Biomedical Research Foundation of the Academy of Athens, Dr. Constantitin Tamvakopoulos 😁
Swipe Left for more...

Only 4 days left for MSc Molecular Biomedicine 6th annual Conference 💪🏼
YOU CAN STILL REGISTER via our Website🔥🎉

Link in bio 🔗

Few days for MolBio conference and we proudly present you our speaker for today, Dr. Theodora Katsila from NHRF, Athens.‼️

We can't wait to meet you 2023😁💪🏼

Stay tuned for more 📣

Registrations are open on our Website ✍️

Link in bio 🔗

MolBio2023 is almost here and we start this day with the announcement of another speaker Mr. Jason Soukas, Mechanical Engineering Intern, ETH Zurich!
Swipe LEFT for more..

You can register now with the link in bio !

Delighted to share the latest update for Molbio2023! 🌟
We’re honored to welcome Servier as our esteemed bronze sponsor, elevating the conference experience.

Servier is an international pharmaceutical group governed by a foundation, founded with the mission to serve health and aspire to have a significant social impact for patients and a sustainable world. With its unique governance model, it is able to fully fulfill its purpose with a long-term vision: to be committed to therapeutic progress to meet the needs of patients. The 21,400 employees of the Group are dedicated to its purpose, which serves as a daily source of inspiration.

As a leader in cardiology, the Servier Group's ambition is to be a recognized, focused, and innovative player in oncology, focusing on challenging-to-treat cancers. For this reason, the Group invests over 50% of its Research & Development budget in developing targeted and innovative therapies in oncology. Neuroscience and inflammatory diseases are future growth drivers. In these therapeutic categories, Servier focuses on a limited number of diseases where the precise patient profile enables precision medicine with the administration of targeted therapies.

In order to provide access to the maximum possible healthcare at a lower cost, the Group also offers a range of quality generic drugs covering most pathological conditions.
For More Information ​Visit Servier : servier.gr

Their support enhances our commitment to precision medicine.🧬✨

Cooper Pharmaceuticals Shines as Silver Sponsor at MolBio2023! 🌐💊

Since its establishment in 1936, Cooper Pharmaceuticals has been an influential presence in the Greek pharmaceutical market. Renowned for its innovative production of parenteral solutions, injectable antibiotics, classic and unique hospital drugs, as well as a comprehensive range of ophthalmic products, Cooper Pharmaceuticals has consistently left an indelible mark.

A Legacy of Success:
Facing challenges with unwavering success, Cooper Pharmaceuticals underwent a transformative phase in 2006. Now fully Greek-owned, the company boasts a new equity and administrative structure, ready to embrace the future with optimism and tackle present challenges head-on.

Strategic Goals and Pillars:

Flexibility, Speed, Adaptability: Core principles that drive the incorporation of new technologies and management methods.
Quality Standards: Rigorous integration of quality standards and control systems in production processes and organizational activities.
Strategic Growth: Utilizing substantial capital funds and a focus on human resource development to become a major force in the pharmaceutical field.
Vision for the Future:
Cooper Pharmaceuticals aims to establish partnerships with major international companies in pharmaceutical medicine and medical devices. The strategic course is anchored in effective service to the medical community and the care of Greek patients.

MolBio2023 Partnership:
As a Silver Sponsor at MolBio2023, Cooper Pharmaceuticals brings its legacy of innovation, adaptability, and commitment to quality to the forefront. Join us to explore the latest advancements in molecular biology, connect with industry leaders, and contribute to shaping the future of healthcare.

Connect with Cooper Pharmaceuticals:
Visit Cooper Pharmaceuticals to learn more about our commitment to pharmaceutical excellence.

🔗 Stay Connected:
Follow MolBio2023 on social media for updates. 🌐🔬

📣NEXT SPEAKER: The Group leader (Researcher C) at the Institute of Biosciences & Applications NCSR "Democritos" Ioannis Sotiropoulos 😁

Only 8 days left for International MSc Molecular Biomedicine 6th annual Conference 💪🏼
YOU CAN STILL REGISTER via our Website🔥🎉

Link in bio 🔗

📣📣 Counting down the days for MolBio Conference 2023 and we are happy to present you our speaker for today, Dr. Olga Papadodima, Functional Research Scientist, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation.
Swipe left for more

FEW DAYS LEFT TO REGISTER ‼️

Link in Bio 🔗